Affordable Access

Publisher Website

Lymphoma-associated mutations in autoreactive memory B cells of patients with Sjögren's syndrome.

Authors
  • Bende, Richard J1, 2, 3
  • Slot, Linda M1, 2, 3
  • Kwakkenbos, Mark J4
  • Wormhoudt, Thera Am1, 2, 3
  • Jongejan, Aldo5
  • Verstappen, Gwenny M6
  • van Kampen, Antoine Cm5, 7
  • Guikema, Jeroen Ej1, 2, 3
  • Kroese, Frans Gm6
  • van Noesel, Carel Jm1, 2, 3
  • 1 Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. , (Netherlands)
  • 2 Lymphoma and Myeloma Center (LYMMCARE), Amsterdam, The Netherlands. , (Netherlands)
  • 3 Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands. , (Netherlands)
  • 4 AIMM Therapeutics, Amsterdam, The Netherlands. , (Netherlands)
  • 5 Bioinformatics Laboratory, Epidemiology & Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. , (Netherlands)
  • 6 Department of Rheumatology and Clinical Immunology, UMC Groningen, University of Groningen, Groningen, The Netherlands. , (Netherlands)
  • 7 Biosystems Data analysis, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands. , (Netherlands)
Type
Published Article
Journal
The Journal of Pathology
Publisher
Wiley (John Wiley & Sons)
Publication Date
Mar 01, 2023
Volume
259
Issue
3
Pages
264–275
Identifiers
DOI: 10.1002/path.6039
PMID: 36426826
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

We recently demonstrated that normal memory B lymphocytes carry a substantial number of de novo mutations in the genome. Here, we performed exome-wide somatic mutation analyses of bona fide autoreactive rheumatoid factor (RF)-expressing memory B cells retrieved from patients with Sjӧgren's syndrome (SS). The amount and repertoire of the de novo exome mutations of RF B cells were found to be essentially different from those detected in healthy donor memory B cells. In contrast to the mutation spectra of normal B cells, which appeared random and non-selected, the mutations of the RF B cells were greater in number and enriched for mutations in genes also found mutated in B-cell non-Hodgkin lymphomas. During the study, one of the SS patients developed a diffuse large B-cell lymphoma (DLBCL) out of an RF clone that was identified 2 years earlier in an inflamed salivary gland biopsy. The successive oncogenic events in the RF precursor clone and the DLBCL were assessed. In conclusion, our findings of enhanced and selected genomic damage in growth-regulating genes in RF memory B cells of SS patients together with the documented transformation of an RF-precursor clone into DLBCL provide unique novel insight into the earliest stages of B-cell derailment and lymphomagenesis. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Report this publication

Statistics

Seen <100 times